Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.10 USD
Change Today 0.00 / 0.00%
Volume 0.0
OWCP On Other Exchanges
As of 8:10 PM 11/20/15 All times are local (Market data is delayed by at least 15 minutes).

owc pharmaceutical research (OWCP) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/11/15 - $0.30
52 Week Low
11/20/15 - $0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

owc pharmaceutical research (OWCP) Related Businessweek News

No Related Businessweek News Found

owc pharmaceutical research (OWCP) Details

OWC Pharmaceutical Research Corp. engages in the research and development of Cannabis-based medical products. The company provides medical products for the treatment of various medical conditions and/or diseases, such as multiple myeloma, psoriasis, PTSD, and migraines; and delivery systems. It is also involved in the development, manufacture, and sale of electronic percussion devices that provide electromagnetic percussion hammer. The company, formerly known as Dynamic Applications Corp., was founded in 2008 and is based in Petach Tikva, Israel.

owc pharmaceutical research (OWCP) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $3.0K
Chief Financial Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

owc pharmaceutical research (OWCP) Key Developments

OWC Pharmaceutical Research Corp. announced delayed 10-Q filing

On 08/14/2015, OWC Pharmaceutical Research Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

OWC Pharmaceutical Research Corp. and Sheba Medical Center to Extend Contract for Fibromyalgia Clinical Trials

OWC Pharmaceutical Research Corp. announced that it has extended its contract with Sheba Academic Medical Center to further conduct clinical trials on fibromyalgia to help to advance better treat patients through the use of medical cannabis. Expected to begin in the middle of the third quarter for 12-15 months, the clinical study is being performed by Professor Howard Amital, Internist and Rheumatologist, Head of Department of Internal Medicine B and Research Center for Autoimmune Diseases at Sheba Academic Medical Center, Tel-Hashomer. Prof. Amital is an Associate Professor in Chair at the Tel Aviv University's Sackler Faculty of Medicine.

OWC Pharmaceutical Research Corp. announced delayed annual 10-K filing

On 03/31/2015, OWC Pharmaceutical Research Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OWCP:US $0.10 USD 0.00

OWCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OWCP.
View Industry Companies

Industry Analysis


Industry Average

Valuation OWCP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 15.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OWC PHARMACEUTICAL RESEARCH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at